Manufacturer or GPO Program year 2025 Source: CMS Open Payments

CSL Behring

PA, United States

CMS manufacturer 100000005563

Open in the dashboard

General payments

$82,262,369

188,523 payments

Research payments

$427,829,341

44,361 payments

Ownership & investment interest

$0

None reported

Through program year 2025, CSL Behring reported paying $82,262,369 in general payments and $427,829,341 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $5,244,847 28,841
2025 Research $56,334,018 7,524
2024 General $4,908,299 27,423
2024 Research $83,254,675 5,934
2023 General $4,205,966 24,341
2023 Research $73,911,662 7,342
2022 General $19,136,466 30,252
2022 Research $41,921,232 8,033
2021 General $17,489,258 28,194
2021 Research $49,709,406 5,425
2020 General $14,550,755 21,502
2020 Research $59,760,125 5,386
2019 General $16,726,779 27,970
2019 Research $62,938,222 4,717

Breakdown

Top recipients General payments · program year 2025
  1. Raffi Tachdjian Allergy & Immunology · Santa Monica, CA $158,288 131 payments
  2. Richard Lemons Pediatric Hematology-Oncology · Salt Lake City, UT $143,819 210 payments
  3. Cristine Radojicic Allergy & Immunology · Durham, NC $125,922 96 payments
  4. Edmund Pezalla Costa Mesa, CA $120,875 9 payments
  5. William Lumry Dallas, TX $103,481 76 payments
  6. The Childrens Hospital Of Philadelp Teaching hospital · PA $84,500 2 payments
  7. Mark Glaum Allergy & Immunology · Tampa, FL $81,712 79 payments
  8. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $80,435 55 payments
  9. Suraj Muley Neurology · Phoenix, AZ $72,278 92 payments
  10. Huamin Li Allergy · Wheaton, MD $71,313 70 payments
Top research recipients Research payments · program year 2025
  1. Duke University $11,616,949 67 payments
  2. Total Renal Research Inc. $9,353,061 909 payments
  3. Frenova, LLC $8,726,659 1,711 payments
  4. National Institute Of Clinical Research $2,360,186 228 payments
  5. North America Research Institute $1,223,653 129 payments
  6. University Of Alabama Hospital Teaching hospital · AL $927,192 27 payments
  7. Metrodora Institute LLC $866,529 54 payments
  8. Elixia Pines LLC $857,557 79 payments
  9. South Florida Research Organization LLC $657,840 37 payments
  10. Velocity Clinical Research, Inc. $574,404 71 payments
Products the payments named General payments · program year 2025
  1. Andembry Hematology $1,522,037 35% · 2,316 recipients
  2. Hizentra Immunology $1,251,513 29% · 4,701 recipients
  3. Hemgenix Hematology $555,333 13% · 118 recipients
  4. Kcentra Trauma (Emergency, Injury, Surgery) $431,158 10% · 2,138 recipients
  5. Idelvion Hematology $225,356 5% · 134 recipients

The top 5 of 17 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $1,310,836 29% · 1,250 practitioners
  2. Pediatric Hematology-Oncology Pediatrics $493,171 11% · 76 practitioners
  3. Neurology Psychiatry & Neurology $446,804 10% · 1,022 practitioners
  4. Allergy Allergy & Immunology $372,199 8% · 232 practitioners
  5. Allergy & Immunology Internal Medicine $159,482 4% · 126 practitioners

The top 5 of 165 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $766,250 15% · 661 recipients
  2. Pennsylvania $479,883 9% · 389 recipients
  3. Florida $363,989 7% · 905 recipients
  4. Texas $321,228 6% · 747 recipients
  5. Arizona $310,190 6% · 193 recipients

The top 5 of 53 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $56,531,648 41,291 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,421,022 3,864 payments
  3. Honoraria $4,583,121 2,001 payments
  4. Food and Beverage $3,452,287 126,656 payments
  5. Travel and Lodging $2,763,667 7,173 payments
  6. Grant $2,675,598 86 payments
  7. Royalty or License $2,627,817 79 payments
  8. Space rental or facility fees (teaching hospital only) $898,507 477 payments
  9. Education $214,253 6,881 payments
  10. Charitable Contribution $94,450 15 payments
Companies with a similar name General payments · program years 2019–2025
  1. CSL Plasma Inc. FL, United States $51,466,563

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

188,523 general · 44,361 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record